Amneal Pharmaceuticals (AMRX) Accounts Payables (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Accounts Payables of $38000.0 for Q1 2026, down 99.37% year-over-year from $6.0 million in Q1 2025, and down 99.93% quarter-over-quarter from $55.5 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Accounts Payables (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Accounts Payables history runs 10 years deep, the most recent figure standing at $38000.0 for Q1 2026.
- In Q1 2026, Accounts Payables fell 99.37% year-over-year to $38000.0; the TTM figure through Mar 2026 stood at $38000.0 (down 99.37% YoY), while the FY2025 annual figure was $55.5 million, up 228.16% from the prior year.
- Accounts Payables for Q1 2026 stood at $38000.0, down from $55.5 million in the prior quarter.
- The five-year high for Accounts Payables was $666.8 million in Q2 2025, with the low at $38000.0 in Q1 2026.
- The 5-year median for Accounts Payables is $11.5 million (2024), against an average of $210.2 million.
- The sharpest annual moves came in 2023 and 2025: Accounts Payables plunged 99.92% in 2023, then surged 30209.86% in 2025.
- Amneal Pharmaceuticals' Accounts Payables stood at $863000.0 in 2022, then slumped by 88.41% to $100000.0 in 2023, then surged by 16808.0% to $16.9 million in 2024, then surged by 228.16% to $55.5 million in 2025, then plunged by 99.93% to $38000.0 in 2026.
- Business Quant data shows AMRX's Accounts Payables at $38000.0 in Q1 2026, $55.5 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | Amneal Pharmaceuticals | 5.72 Bn | 5.59 Bn | 334.51 Mn | 721.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 721.21 Mn |
| Mar 31, 2026 | 38,000.00 |
| Dec 31, 2025 | 55.49 Mn |
| Sep 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 666.82 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 16.91 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | 442,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 442,000.00 |
| Jun 30, 2023 | 512.72 Mn |
| Mar 31, 2023 | 467.42 Mn |
| Dec 31, 2022 | 863,000.00 |
| Sep 30, 2022 | 531.46 Mn |
| Jun 30, 2022 | 561.69 Mn |
| Mar 31, 2022 | 539.73 Mn |
| Dec 31, 2021 | 525.35 Mn |
| Sep 30, 2021 | 589.41 Mn |
| Jun 30, 2021 | 596.23 Mn |